Role of the Akt Pathway in Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
163-175
Author(s):
Paul L. de Souza, Pamela J. Russell and John Kearsley
Nitric Oxide: Cancer Target or Anticancer Agent?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
214-236
Author(s):
Simone Mocellin
Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
950-956
Author(s):
Steven M. Larson
Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
988-1007
Author(s):
Tomi Heiskanen, Tomas Heiskanen and Kalevi Kairemo
Editorial:Hot Topic: [Anti-Cancer Drugs(Executive Editor: Elke Bergmann-Leitner)]
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
730-731
Author(s):
Elke Bergmann-Leitner
Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
732-741
Author(s):
R. Pandey, R. Chander and K. B. Sainis
Chemokine Receptors as Targets for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
742-757
Author(s):
Xuesong Wu, Vivian C. Lee, Eric Chevalier and Sam T. Hwang
Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
777-791
Author(s):
Di Chen, Vesna Milacic, Michael Frezza and Q. Ping Dou
Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-κB Inhibitor DHMEQ
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
792-808
Author(s):
Alina Katsman, Kazuo Umezawa and Benjamin Bonavida
Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
809-825
Author(s):
Sven Mostbock